Showing results (91-100 of 105) with videos related to
Sort By:
Pageof 11
British Journal of Cancer|February 6, 2026
Exposure-response relationship of nivolumab and ipilimumab in patients with metastatic renal cell carcinoma from the randomised phase 2 BIONIKK studyBenoit Blanchet, Alicja Puszkiel, Anne Jouinot, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2013
Characteristics and clinical impacts of the immune environments in colorectal and renal cell carcinoma lung metastases: influence of tumor originRomain Remark, Marco Alifano, Isabelle Cremer, et al.Communications Biology|March 4, 2026
Intracellular complement Factor H promotes tumor progression through modulation of cell cycle and actin cytoskeletonMikel Rezola Artero, Andrea Minery, Margot Revel, et al.Blood|September 13, 2011
A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumor immunity against self antigensHelene Pere, Yves Montier, Jagadeesh Bayry, et al.Immunity|March 1, 2022
Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancerMaxime Meylan, Florent Petitprez, Etienne Becht, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2022
An Enhancer Demethylator Phenotype Converged to Immune Dysfunction and Resistance to Immune Checkpoint Inhibitors in Clear-Cell Renal Cell CarcinomasXiaofan Lu, Yann Vano, Alexandra Helleux, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2005
CCL1-CCR8 interactions: an axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammationMichael Gombert, Marie-Caroline Dieu-Nosjean, Franziska Winterberg, et al.Cancer Cell|July 9, 2026
GABA promotes resistance to immunotherapy in patients with TLS-positive tumorsIsaias Hernández-Verdin, Anne Calvez, Cheng-Ming Sun, et al.European Urology|November 12, 2025
Nivolumab in Metastatic Clear-cell Renal Cell Carcinoma: An Integrative Biomarker Analysis from the NIVOREN GETUG-AFU 26 Phase 2 StudyRonan Flippot, Yann-Alexandre Vano, Cécile Dalban, et al.Science Immunology|July 26, 2024
Timing and location dictate monocyte fate and their transition to tumor-associated macrophagesGarett Dunsmore, Wei Guo, Ziyi Li, et al.Pageof 11